Quantifying beta-agonist utilization: Occasions or puffs?

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1088-1090. doi: 10.1016/j.jaip.2018.08.037. Epub 2018 Sep 13.

Authors

Stanley J Szefler¹, Heather E Hoch¹, Michael Tuffli², Rahul Gondalia³, Meredith A Barrett², David Van Sickle⁴, David A Stempel²

Affiliations

¹ Breathing Institute, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colo.
² Propeller Health, San Francisco, Calif.
³ Propeller Health, San Francisco, Calif. Electronic address: [email protected].
⁴ Propeller Health, Madison, Wis.

PMID: 30218718
DOI: 10.1016/j.jaip.2018.08.037

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adrenergic beta-2 Receptor Agonists / administration & dosage*
Adult
Albuterol / administration & dosage*
Asthma / drug therapy*
Bronchodilator Agents / administration & dosage*
Drug Administration Schedule
Humans

Substances

Adrenergic beta-2 Receptor Agonists
Bronchodilator Agents
Albuterol